ReviewCurrent hematologic malignancy reports2015

Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?

Lara E Sucheston-Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.